ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AH04 | G | Quetiapine fumarate - 300mg | 10706 | 93020/1 | SEROPINE XR 300 | 300mg | 60 | Tablet, extended release | Oral | Benta Trading Co s.a.l. | Manufactured by Intas Pharmaceuticals Limited, India for Benta SAL | Lebanon | 4,744,660 L.L | 23.08 | B | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AH04 | G | Quetiapine fumarate - 300mg | 11077 | 164620/1 | QUETIAPINE BIOGARAN L.P. | 300mg | 30 | Tablet, prolonged release | Oral | Commercial and Trading Ressources SAL (CTR) | Pharmathen International SA | Greece | 1,759,090 L.L | 23.08 | B | Laboratoires Biogaran | France | 2/5/2024 | 0 |
N05AH04 | G | Quetiapine fumarate - 300mg | 7982 | 186125/13 | REZAL XR | 300mg | 30 | Tablet, extended release | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2,535,831 L.L | 23.08 | B | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |